Gunnar Knell News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Envestnet Asset Management Inc. lifted its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 8.3% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 179,954 shares of the medical research company’s stock after purchasing an additional 13,741 shares during […]

Legacy Wealth Asset Management LLC grew its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 6.6% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 3,358 shares of the medical research company’s stock after […]

Charles River Laboratories International (NYSE:CRL – Free Report) had its price target cut by TD Cowen from $212.00 to $209.00 in a report released on Monday, Benzinga reports. They currently have a market perform rating on the medical research company’s stock. CRL has been the topic of a number of other reports. Robert W. Baird […]

Charles River Laboratories International (NYSE:CRL – Free Report) had its target price reduced by Wells Fargo & Company from $280.00 to $275.00 in a research report released on Friday morning, Marketbeat Ratings reports. They currently have an overweight rating on the medical research company’s stock. A number of other equities research analysts have also recently […]

Confluence Investment Management LLC acquired a new stake in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) in the 2nd quarter, Holdings Channel reports. The fund acquired 84,001 shares of the medical research company’s stock, valued at approximately $17,661,000. Several other institutional investors and hedge funds have also made changes to their positions in […]